Clinical significance of prostatic acid phosphatase assay as a tumor marker
Kuriyama, M.; Takahashi, Y.; Kawada, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 925-927
1990
ISSN/ISBN: 0047-1852 PMID: 2355633 Document Number: 360308
Document emailed within 1 workday
Related Documents
Benvenuti, M.; Legnaioli, M.; Melone, F.; Taddei, I.; Tarquini, B. 1983: Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa) Chronobiologia 10(4): 383-386Hara, K.; Mitsuhashi, F.; Ohkura, H. 1990: Clinical significance of CA 50 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 971-973
Kubota, S. 1990: Clinical significance of polyamine assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 953-956
Kimura, T.; Nawata, H. 1990: Clinical significance of elastase 1 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 899-902
Kato, H. 1990: Clinical significance of SCC antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1057-1059
Endo, J.; Nagaoka, S.; Kannagi, R. 1990: Clinical significance of sialyl SSEA-1 assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1008-1012
Fujino, M.; Endo, Y. 1990: Clinical significance of carcinoembryonic antigen assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 907-911
Yamano, M. 1990: Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 999-1002
Nakagawa, C.; Tsukahara, T.; Shimatake, H. 1990: Clinical significance of anti human N-myc protein antibody assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 942-945
Lamy, S.; Borsi, C.; Humbel, R. 1983: The value of counterimmunoelectrophoresis for the assay of prostatic acid phosphatase Acta Urologica Belgica 51(3): 340-344
Zattoni, F.; Passerini Glazel, G.; Tasca, A.; Scialino, G.; Cavazzana, A. 1985: Acid phosphatase and prostatic cancer. Survey of present assay methods Minerva Urologica e Nefrologica 37(2): 113-116
Paoli, C.; Bardelli, F.; Tarli, P.; Neri, P. 1982: A simple and rapid immunoenzymatic assay of prostatic acid phosphatase in serum Annales de Biologie Clinique 40(2): 75-78
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Yamaguchi, K.; Tanaka, M.; Kitagawa, N.; Kotake, T.; Yanagi, S.; Ito, H. 1989: The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers Hinyokika Kiyo. Acta Urologica Japonica 35(6): 987-991
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Zweig, M.H.; Van Steirteghem, A.C. 1981: Assessment of radioimmunoassay of serum creatine kinase BB (CK-BB) as a tumor marker: studies in patients with various cancers and a comparison of CK-BB concentrations to prostate acid phosphatase concentrations Journal of the National Cancer Institute 66(5): 659-662
Inoue, M.; Saitoh, J.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Gamoh, Y.; Dan, A.; Satoh, T. 1985: Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies Nihon Sanka Fujinka Gakkai Zasshi 37(11): 2411-2414
Leńko, J.; Marczyńska, A.; Kulpa, J.; Kwinta, A.; Bugajski, A. 1986: Biochemical control investigations (determinations of prostatic phosphatase--carcinoembryonic antigen alkaline phosphatase) in patients treated for prostatic carcinoma. Preliminary estimation of effectiveness Materia Medica Polona. Polish Journal of Medicine and Pharmacy 18(4): 238-243
Sheth, A.R.; Garde, S.V.; Mehta, M.K.; Shah, M.G. 1992: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide Indian Journal of Experimental Biology 30(3): 157-161